patients receive chemotherapy with paclitaxel and carboplatin. In early-stage nonserous epithelial ovarian cancer, 3 cycles have been shown to be as effective as 6 Figure 1. Characteristics of ovarian cancer subtypes. Abbreviation: MP
Search Results
Amit G. Singal, Akbar K. Waljee, Nishant Patel, Emerson Y. Chen, Jasmin A. Tiro, Jorge A. Marrero, and Adam C. Yopp
greater than 200 ng/mL, or histologic confirmation for tumors larger than 1 cm. 20 Tumor characteristics were determined by imaging studies, which had all been interpreted by radiologists at the authors’ institution, and tumor staging was performed using
Andrea Maurichi, Rosalba Miceli, Roberto Patuzzo, Francesco Barretta, Gianfranco Gallino, Ilaria Mattavelli, Consuelo Barbieri, Andrea Leva, Umberto Cortinovis, Elena Tolomio, Milena Sant, Gianpiero Castelli, Leonardo Zichichi, Giovanni Pellacani, Ignazio Stanganelli, Marco Simonacci, Ausilia Manganoni, Corrado Del Forno, Gioachino Caresana, Catherine Harwood, Daniele Bergamaschi, Konstantinos Lasithiotakis, Dorothy Bennett, Vittoria Espeli, Cristina Mangas, Sandra Leoni Parvex, Barbara Valeri, Mara Cossa, Marta Barisella, Alessandro Pellegrinelli, Claudia Miranda, Andrea Anichini, Roberta Mortarini, Odysseas Zoras, and Mario Santinami
completion lymph node dissection (CLND) as additional therapy. Statistical Methods Clinicopathologic characteristics were recorded according to SNB (performed vs not performed) for the whole series of patients, according to SN status (positive vs negative) in
Sarju Ganatra, Sourbha S. Dani, Robert Redd, Kimberly Rieger-Christ, Rushin Patel, Rohan Parikh, Aarti Asnani, Vigyan Bang, Katherine Shreyder, Simarjeet S. Brar, Amitoj Singh, Dhruv S. Kazi, Avirup Guha, Salim S. Hayek, Ana Barac, Krishna S. Gunturu, Corrine Zarwan, Anne C. Mosenthal, Shakeeb A. Yunus, Amudha Kumar, Jaymin M. Patel, Richard D. Patten, David M. Venesy, Sachin P. Shah, Frederic S. Resnic, Anju Nohria, and Suzanne J. Baron
and CVD. Abbreviation: CVD, cardiovascular disease. Patient Characteristics Baseline characteristics of patients with COVID-19 are shown in Table 1 . Patients with COVID-19 and a history of cancer were older (aged 77 vs 57 years; P <.001) and more
Kate Watabayashi, Jordan Steelquist, Karen A. Overstreet, Anthony Leahy, Erin Bradshaw, Kathleen D. Gallagher, Alan J. Balch, Rebecca Lobb, Laura Lavell, Hannah Linden, Scott D. Ramsey, and Veena Shankaran
–caregiver dyads to an oncology financial navigation program. We describe the demographic and financial characteristics of enrolled subjects, the assistance provided to participants by our navigation partners, participants’ overall satisfaction with the program
Danielle N. Blunt, Liam Smyth, Chenthila Nagamuthu, Evgenia Gatov, Ruth Croxford, Lee Mozessohn, and Matthew C. Cheung
with >15 days from diagnosis to treatment initiation (DTI) had lower-risk characteristics and improved event-free survival (EFS) at 24 months from diagnosis compared with patients treated more urgently. Furthermore, a retrospective, observational study
Demetra Hypatia Hufnagel, Sumit Tushar Mehta, Chinyere Ezekwe, Alaina J. Brown, Alicia Beeghly-Fadiel, and Lauren Shore Prescott
version 3.4.4 (R Foundation for Statistical Computing). Univariate and multivariable regression were performed using SAS 9.4 (SAS Institute Inc) to evaluate the associations between clinical characteristics and anemia prevalence, evaluation, and treatment
Apostolia M. Tsimberidou, Alexandra M. Adamopoulos, Yang Ye, Sarina Piha-Paul, Filip Janku, Siqing Fu, David Hong, Gerald S. Falchook, Aung Naing, Jennifer Wheler, Adoneca Fortier, Razelle Kurzrock, and Kenneth R. Hess
date of last follow-up were censored on that date. The patient characteristics were analyzed using descriptive statistics. Survival functions were estimated using the Kaplan-Meier method. Results Demographics From July 2010 to December
Eric J. Roeland, Daniel P. Triplett, Rayna K. Matsuno, Isabel J. Boero, Lindsay Hwang, Heidi N. Yeung, Loren Mell, and James D. Murphy
after cancer diagnosis. Regional Covariates This study evaluated the association between the regional use of cancer-related palliative care and regional health care characteristics. Regional geography was evaluated at the level of hospital
Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah
characteristics, type of malignancy, and survival duration; however, it did not provide information on patient symptoms, performance status, cytogenetics, MRD, treatment drugs, stem cell transplantation, or other prognostic factors. Selection criteria for this
